NYMC Faculty Publications
Unbiased Proteomics Identifies Plasminogen Activator Inhibitor-1 as a Negative Regulator of Endothelial Nitric Oxide Synthase
Nitric oxide (NO) produced by endothelial nitric oxide synthase (eNOS) is a critical mediator of vascular function. eNOS is tightly regulated at various levels, including transcription, co- and posttranslational modifications, and by various protein-protein interactions. Using stable isotope labeling with amino acids in cell culture (SILAC) and mass spectrometry (MS), we identified several eNOS interactors, including the protein plasminogen activator inhibitor-1 (PAI-1). In cultured human umbilical vein endothelial cells (HUVECs), PAI-1 and eNOS colocalize and proximity ligation assays demonstrate a protein-protein interaction between PAI-1 and eNOS. Knockdown of PAI-1 or eNOS eliminates the proximity ligation assay (PLA) signal in endothelial cells. Overexpression of eNOS and HA-tagged PAI-1 in COS7 cells confirmed the colocalization observations in HUVECs. Furthermore, the source of intracellular PAI-1 interacting with eNOS was shown to be endocytosis derived. The interaction between PAI-1 and eNOS is a direct interaction as supported in experiments with purified proteins. Moreover, PAI-1 directly inhibits eNOS activity, reducing NO synthesis, and the knockdown or antagonism of PAI-1 increases NO bioavailability. Taken together, these findings place PAI-1 as a negative regulator of eNOS and disruptions in eNOS-PAI-1 binding promote increases in NO production and enhance vasodilation in vivo.
Garcia, V., Park, E. J., Siragusa, M., Frohlich, F., Mahfuzul Haque, M., Pascale, J. V., Heberlein, K. R., Isakson, B. E., Stuehr, D. J., & Sessa, W. C. (2020). Unbiased Proteomics Identifies Plasminogen Activator Inhibitor-1 as a Negative Regulator of Endothelial Nitric Oxide Synthase. Proceedings of the National Academy of Sciences of the United States of America, 117 (17), 9497-9507. https://doi.org/10.1073/pnas.1918761117